Stephan Quentzel
Psychiatry · New York City, NYNPI 1699817080
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $122,260 of the $137,953 with a category attached, or 88.6%. 17 manufacturers reported payments, led by Alkermes, Inc. at 51.4% of the total. Reporting peaked in 2022 at $42,289 and has fallen 84.1% since, to $6,718 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 419 payments — averaging $329.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$71K
- AbbVie$60K
- Sunovion Pharmaceuticals Inc.$5K
- Lundbeck LLC$576
- Teva Pharmaceuticals USA, Inc.$436
- Bausch Health US, LLC$389
- plus $803 from 11 others
What the payments were for
- Speaking & faculty fees$122,26089%
- Travel & lodging$7,5275%
- Food & beverage$8,0536%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 117 | $70,861 |
| AbbVie(2 entities) | 178 | $59,771 |
| Sunovion Pharmaceuticals Inc. | 27 | $5,117 |
| Lundbeck LLC | 34 | $576 |
| Teva Pharmaceuticals USA, Inc. | 13 | $436 |
| Bausch Health US, LLC | 17 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| Supernus Pharmaceuticals, Inc. | 5 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $118 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Harmony Biosciences LLC | 1 | $57 |
| Avanir Pharmaceuticals, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 3 | $46 |
| Merck | 2 | $29 |
| Alfasigma USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$137,953 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 27 | $1,197 |
| Duloxetine Hcl | 16 | $878 |
| Aripiprazole | 16 | $822 |
| Mirtazapine | 15 | $238 |
| Gabapentin | 18 | $225 |
| Trazodone Hcl | 17 | $214 |
| Zolpidem Tartrate | 25 | $108 |
| Clonazepam | 11 | $107 |
| Fluoxetine Hcl | 15 | $103 |
| Diazepam | 11 | $66 |
| Alprazolam | 15 | $48 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in New York City
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.